Avascular necrosis (AVN) of the head of femur is a progressive orthopedic condition characterized by compromised blood supply to the femoral head, leading to bone ischemia, structural collapse, and secondary osteoarthritis if untreated. It commonly affects young and middle-aged adults and is associated with risk factors such as corticosteroid use, alcohol abuse, trauma, and certain systemic diseases. Clinical presentation ranges from asymptomatic early disease to severe hip pain and functional limitation in advanced stages. Diagnosis relies on clinical suspicion supported by imaging, with magnetic resonance imaging (MRI) being the gold standard for early detection. Management strategies depend on disease stage and include conservative measures, pharmacologic therapy, joint-preserving surgical procedures, and total hip arthroplasty in advanced cases. This case report describes a young patient with avascular necrosis of the femoral head, highlighting clinical features, diagnostic evaluation, management, and short-term outcomes. Early diagnosis and timely intervention are essential to delay disease progression and preserve joint function.
Avascular necrosis of the femoral head is a debilitating condition resulting from interruption of the blood supply to the subchondral bone, leading to osteocyte death and eventual collapse of the femoral head. The condition predominantly affects individuals between 20 and 50 years of age and has significant socioeconomic implications due to functional disability.
Common etiological factors include prolonged corticosteroid therapy, excessive alcohol consumption, trauma, hematological disorders, autoimmune diseases, and idiopathic causes. Early stages may be clinically silent, making diagnosis challenging. However, progression of the disease leads to persistent hip pain, reduced range of motion, and impaired mobility. Advances in imaging and surgical techniques have improved early detection and outcomes, but delayed diagnosis often necessitates joint replacement. This case report aims to illustrate the clinical course, diagnostic approach, and management of avascular necrosis of the femoral head in a pediatric patient.
A 14-year-old male presented to the orthopedic outpatient clinic with a history of progressive left hip pain for three months. The pain was insidious in onset, dull in character, localized to the groin region, and exacerbated by weight-bearing and physical activity. The patient reported difficulty in walking long distances and occasional limping.
There was no history of trauma, fever, or infection. Past medical history revealed intermittent corticosteroid use for nephrotic syndrome over the previous two years. There was no history of alcohol consumption, chronic illness, or similar complaints in the family.
On examination, the patient had an antalgic gait favoring the left lower limb.

Vital signs were stable. Local examination of the left hip revealed tenderness in the groin region and restriction of internal rotation and abduction.

Flexion was mildly painful at the extremes of motion. No limb length discrepancy was noted. Examination of the contralateral hip and other joints was normal. Neurological and vascular examinations were unremarkable.
The differential diagnosis for chronic hip pain in an adolescent included:
Investigations


The patient was managed with a joint-preserving approach due to early-stage disease and young age. Management included:
At three-month follow-up, the patient reported significant reduction in pain and improvement in gait. Hip range of motion improved, and radiological evaluation showed no progression of femoral head collapse. At six months, the patient was able to resume routine activities with minimal discomfort. Long-term follow-up was planned to monitor disease progression and functional outcomes.
Avascular necrosis of the femoral head is a progressive condition that can lead to irreversible joint damage if not identified early. Corticosteroid use is one of the most significant non-traumatic risk factors, particularly in pediatric and adolescent populations with chronic systemic illnesses. The pathogenesis involves lipid metabolism alterations, increased intraosseous pressure, and microvascular compromise.
MRI is the most sensitive modality for early diagnosis, allowing detection before radiographic changes become evident. Early-stage disease can be managed with conservative and joint-preserving surgical techniques such as core decompression, which aims to restore blood flow and delay disease progression. Advanced stages often require total hip arthroplasty, which is less desirable in young patients due to implant longevity concerns.
Multidisciplinary management, early intervention, and patient education are critical to improving outcomes. Regular follow-up is essential to detect progression and guide timely escalation of treatment.
Avascular necrosis of the head of femur is a serious orthopedic condition with the potential for significant morbidity, particularly in young patients. Early recognition through careful clinical assessment and prompt imaging with MRI enables timely intervention and joint preservation. Identification and modification of risk factors, appropriate pharmacologic therapy, and surgical management tailored to disease stage are essential for optimal outcomes. A multidisciplinary approach, combined with patient and family education, plays a pivotal role in preventing disease progression and maintaining long-term hip function. With early diagnosis and appropriate treatment, patients can achieve pain relief, functional improvement, and delayed need for joint replacement.
Parfitt, A. M. (1994). Osteonecrosis: Pathogenesis and classification. Clinical Orthopaedics and Related Research, 292, 10–21. https://journals.lww.com/clinorthop/Abstract/1994/01000/Osteonecrosis__Pathogenesis_and_Classification.3.aspx
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
2.
Investigating the Relationship Between GERD and Anxiety/Depression.
3.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
4.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
5.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
1.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
2.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
3.
Vaccines that can help prevent cancer
4.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
5.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation